Article

Announcing Hope Series Webinar From Hope For Stomach Cancer

Author(s):

Hope for Stomach Cancer

Join us for our Inaugural 1st Hope Webcast on surgical strategies for Stage IV stomach cancer.

Join us for our Inaugural 1st Hope Webcast on surgical strategies for Stage IV stomach cancer.
IP Chemo | PIPAC | HIPEC

Moderated by Samuel Klempner, M.D., a Gastrointestinal Oncologist at Massachusetts General Hospital, and will include a presentation of the importance of a multidisciplinary team in peritoneal-directed therapies.



The following topics will be covered by world-renown panelists:
IP Chemo - Dr. Andrew M. Blakely
PIPAC - Dr. Yanghee Woo
HIPEC - Dr. Brian D. Badgwell

Following the presentations, there will be a LIVE panel discussion and they will be taking questions.

The first interactive webcast will educate and help self-empower better care management for:
• Patients
• Caregivers
• Loved-ones

This webcast is FREE. Registration Required!

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
New or persistent acid reflux, especially after age 50, may mean higher risk for esophageal cancer, particularly in people with other known risk factors.
Image of Kumar.
Image of Dr. Uboha.
Image of Dr. Kumar.
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Bald Doctor.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Dr. Kim in an interview with CURE
Related Content
Image of stomach.
June 2nd 2025

Imfinzi Combo Boosts Survival in Resectable Gastric and GEJ Cancer

Chris Ryan
Adding Imfinzi to fluorouracil-based chemo improved event-free survival and response rates in resectable gastric and gastroesophageal junction cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Clinical trials text.
April 21st 2025

Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers

Spencer Feldman
Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Image of man holding stomach.
April 6th 2025

FDA Grants HLX22 Orphan Drug Designation for Gastric Cancer

Spencer Feldman
FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.
Illustration of body.
April 3rd 2025

NG-350A Evaluated in FORTRESS Trial for Locally Advanced Rectal Cancer

Ryan Scott
The first patient with locally advanced rectal cancer has been enrolled in the FORTRESS study which is evaluating the investigative immunotherapy NG-350A.